Chang-Yuil Kang

7PUBLICATIONS
18CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsImmunogenetics (incl. genetic immunology)Molecular targetsInformation systems development methodologies and practiceInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 25, 2025
Evaluation of Simultaneous Production Strategies for Adenoviral Vector-Based SARS-CoV-2 Multivalent Vaccines via an Expanded Allele-specific Competitive Blocker PCR Quantification Method.

Soojeong Chang, Hyemin Park, Jieun Shin

|Feb 01, 2025
Continuous Tracking for Effective Tackling: Ad5/35 Platform-Based JN1 Lineage Vaccines Development in Response to Evolving SARS-CoV-2 Variants.

Soojeong Chang, Jieun Shin, Seowoo Park

|Mar 08, 2024
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials.

Choong-Hyun Koh, Byung-Seok Kim, Chang-Yuil Kang

|Feb 26, 2024
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.

Soojeong Chang, Kwang-Soo Shin, Bongju Park

|Jul 11, 2018
CX3CR1+ Macrophages and CD8+ T Cells Control Intestinal IgA Production.

Young-In Kim, Joo-Hye Song, Hyun-Jeong Ko

|Jun 07, 2017
IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours.

Hyungseok Seo, Insu Jeon, Byung-Seok Kim

Pageof 2

Frequent Collaborators

3 joint publications

Soojeong Chang

2 joint publications

Yeonseok Chung

2 joint publications

Bongju Park

2 joint publications

Seowoo Park